| Anteris Technologies Global Corp. | 5.55M | US$54.6M | 9.0% |
| Cencora, Inc. | 174K | US$49.1M | 8.1% |
| Maximus, Inc. | 715K | US$38.5M | 6.4% |
| Allogene Therapeutics, Inc. | 13.3M | US$27.7M | 4.6% |
| Globus Medical, Inc. | 302K | US$23.8M | 3.9% |
| Gsk Plc | 437K | US$22.9M | 3.8% |
| Tyra Biosciences, Inc. | 695K | US$22.2M | 3.7% |
| Waystar Holding Corp. | 926K | US$19M | 3.1% |
| Ideaya Biosciences, Inc. | 480K | US$17.9M | 3.0% |
| Oruka Therapeutics, Inc. | 177K | US$16.9M | 2.8% |
| The Cigna Group | 57,750 | US$15.9M | 2.6% |
| Sanofi Sa | 364K | US$15.5M | 2.6% |
| Viatris Inc. | 954K | US$15.2M | 2.5% |
| Cross Country Healthcare, Inc. | 1.1M | US$14.5M | 2.4% |
| Rapport Therapeutics, Inc. | 308K | US$12.8M | 2.1% |
| Abbott Laboratories | 129K | US$11.7M | 1.9% |
| Celcuity Inc. | 110K | US$11.5M | 1.9% |
| Zimmer Biomet Holdings, Inc. | 131K | US$11.3M | 1.9% |
| Regeneron Pharmaceuticals, Inc. | 18,000 | US$11.2M | 1.9% |
| Bristol-myers Squibb Company | 194K | US$11.1M | 1.8% |
| Vir Biotechnology, Inc. | 1.08M | US$11M | 1.8% |
| Senseonics Holdings, Inc. | 1.59M | US$9.05M | 1.5% |
| Eyepoint, Inc. | 623K | US$8.91M | 1.5% |
| Cybin, Inc. | 1.3M | US$8.59M | 1.4% |
| Ani Pharmaceuticals, Inc. | 97,305 | US$8.05M | 1.3% |
| Protara Therapeutics, Inc. | 1.92M | US$7.34M | 1.2% |
| Relmada Therapeutics, Inc. | 1M | US$6.94M | 1.1% |
| Tango Therapeutics, Inc. | 209K | US$6.52M | 1.1% |
| Aquestive Therapeutics, Inc. | 1.49M | US$6.18M | 1.0% |
| Dianthus Therapeutics, Inc. | 59,254 | US$5.78M | 0.96% |
| Sionna Therapeutics, Inc. | 128K | US$5.62M | 0.93% |
| Ocular Therapeutix, Inc. | 539K | US$5.3M | 0.88% |
| Zenas Biopharma, Inc. | 209K | US$5.29M | 0.88% |
| Bright Minds Biosciences Inc. | 73,952 | US$5.19M | 0.86% |
| Onkure Therapeutics, Inc. | 1.08M | US$4.92M | 0.81% |
| Savara, Inc. | 618K | US$3.8M | 0.63% |
| Pmv Pharmaceuticals, Inc. | 2.63M | US$3.53M | 0.58% |
| Aveanna Healthcare Holdings Inc. | 369K | US$3.16M | 0.52% |
| Ovid Therapeutics Inc. | 1.01M | US$2.7M | 0.45% |
| Immunome, Inc. | 124K | US$2.63M | 0.44% |
| An2 Therapeutics, Inc. | 530K | US$2.56M | 0.42% |
| Serina Therapeutics, Inc. | 1M | US$1.94M | 0.32% |
| Aligos Therapeutics, Inc. | 327K | US$1.89M | 0.31% |
| Ibio, Inc. | 904K | US$1.58M | 0.26% |
| Xilio Therapeutics, Inc. | 152K | US$1.46M | 0.24% |
| Artivion, Inc. | 48,481 | US$1.09M | 0.18% |
| Bridgebio Oncology Therapeutics, Inc. | 131K | US$995K | 0.16% |
| Tela Bio, Inc. | 636K | US$477K | 0.08% |
| Adagio Medical Holdings, Inc | 699K | US$455K | 0.08% |
| Neuroone Medical Technologies Corporation | 82,767 | US$252K | 0.04% |
| Enveric Biosciences, Inc. | 180K | US$248K | 0.04% |
| Modular Medical, Inc. | 26,190 | US$118K | 0.02% |
| Qt Imaging Holdings, Inc. | 15,236 | US$62,011 | 0.01% |
| Biomarin Pharmaceutical Inc. | 0 | US$0 | 0.00% |
| Boundless Bio, Inc. | 0 | US$0 | 0.00% |
| Context Therapeutics Inc. | 0 | US$0 | 0.00% |
| Corcept Therapeutics Incorporated | 0 | US$0 | 0.00% |
| Crinetics Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Disc Medicine, Inc. | 0 | US$0 | 0.00% |
| Edgewise Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Embecta Corp. | 0 | US$0 | 0.00% |
| Enanta Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Erasca, Inc. | 0 | US$0 | 0.00% |
| Foghorn Therapeutics Inc. | 0 | US$0 | 0.00% |
| Haemonetics Corporation | 0 | US$0 | 0.00% |
| Hyperfine, Inc. | 0 | US$0 | 0.00% |
| Integra Lifesciences Holdings Corporation | 0 | US$0 | 0.00% |
| Kymera Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Monopar Therapeutics Inc. | 0 | US$0 | 0.00% |
| Organon & Co. | 0 | US$0 | 0.00% |
| Quidelortho Corporation | 0 | US$0 | 0.00% |
| Replimune Group, Inc. | 0 | US$0 | 0.00% |
| Shoulder Innovations, Inc. | 0 | US$0 | 0.00% |
| Simulations Plus, Inc. | 0 | US$0 | 0.00% |
| Teleflex Incorporated | 0 | US$0 | 0.00% |
| Terns Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Abivax Sa | 0 | US$0 | 0.00% |
| Biohaven Ltd. | 0 | US$0 | 0.00% |